Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

This publication has 41 references indexed in Scilit:

• Intracellular Role for Sphingosine Kinase 1 in Intestinal Adenoma Cell Proliferation
  Molecular and Cellular Biology, 2006
• The Differential Staurosporine-Mediated G1 Arrest in Normal versus Tumor Cells Is Dependent on the Retinoblastoma Protein
  Cancer Research, 2006
• Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer
  Cancer Research, 2006
• Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• JC‐1, a sensitive probe for a simultaneous detection of P‐glycoprotein activity and apoptosis in leukemic cells
  Cytometry Part B: Clinical Cytometry, 2006
• Targeting multidrug resistance in cancer
  Nature Reviews Drug Discovery, 2006
• Effect of the Farnesyl Transferase Inhibitor L-744,832 on the Colon Cancer Cell Line DLD-1 and Its Combined Use with Radiation and 5-FU
  Chemotherapy, 2005
• New-generation platinum drugs in the treatment of cisplatin-resistant cancers
  Expert Opinion on Investigational Drugs, 2005
• Tumour stem cells and drug resistance
  Nature Reviews Cancer, 2005
• Strategies for reversing drug resistance
  Oncogene, 2003